Inactivation of Rho GTPases by statins attenuates anthrax lethal toxin activity

Infection and Immunity

Volumn 77, Issue 1, 2009, Pages 348-359

  DeCathelineau, Aimee M ^a,b   Bokoch, Gary M ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; BACILLUS ANTHRACIS; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MACROPHAGES; MICE; RHO GTP-BINDING PROTEINS;

EID: 58449083911     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01005-08     Document Type: Article

References (87)

1. Abrami, L., M. Lindsay, R. G. Parton, S. H. Leppla, and F. G. van der Goot. 2004. Membrane insertion of anthrax protective antigen and cytoplasmic delivery of lethal factor occur at different stages of the endocytic pathway. J. Cell Biol. 166:645-651.
2. Abrami, L., S. Liu, P. Cosson, S. H. Leppla, and F. G. van der Goot. 2003. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J. Cell Biol. 160:321-328.
3. Agrawal, A., J. Lingappa, S. H. Leppla, S. Agrawal, A. Jabbar, C. Quinn, and B. Pulendran. 2003. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 424:329-334.
4. Aktories, K., and A. Wegner. 1992. Mechanisms of the cytopathic action of actin-ADP-ribosylating toxins. Mol. Microbiol. 6:2905-2908.
5. Anderson, D. H. 2006. Role of lipids in the MAPK signaling pathway. Prog. Lipid Res. 45:102-119.
6. Barth, H., K. Aktories, M. R. Popoff, and B. G. Stiles. 2004. Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol. Mol. Biol. Rev. 68:373-402.
7. Beauregard, K. E., R. J. Collier, and J. A. Swanson. 2000. Proteolytic activation of receptor-bound anthrax protective antigen on macrophages promotes its internalization. Cell Microbiol. 2:251-258.
8. Benard, V., and G. M. Bokoch. 2002. Assay of Cdc42, Rac, and Rho GTPase activation by affinity methods. Methods Enzymol. 345:349-359.
9. Bokoch, G. M. 2005. Regulation of innate immunity by Rho GTPases. Trends Cell Biol. 15:163-171.
10. Bokoch, G. M., and V. Prossnitz. 1992. Isoprenoid metabolism is required for stimulation of the respiratory burst oxidase of HL-60 cells. J. Clin. Investig. 89:402-408.
11. Bowman, E. J., A. Siebers, and K. Altendorf. 1988. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc. Natl. Acad. Sci. USA 85:7972-7976.
12. Bradley, K. A., J. Mogridge, M. Mourez, R. J. Collier, and J. A. Young. 2001. Identification of the cellular receptor for anthrax toxin. Nature 414:225-229.
13. Chen, J. C., K. C. Huang, B. Wingerd, W. T. Wu, and W. W. Lin. 2004. HMG-CoA reductase inhibitors induce COX-2 gene expression in murine macrophages: role of MAPK cascades and promoter elements for CREB and C/EBPβ. Exp. Cell Res. 301:305-319.
14. Chopra, A. P., S. A. Boone, X. Liang, and N. S. Duesbery. 2003. Anthrax lethal factor proteolysis and inactivation of MAPK kinase. J. Biol. Chem. 278:9402-9406.
15. Collier, R. J., and J. A. Young. 2003. Anthrax toxin. Annu. Rev. Cell Dev. Biol. 19:45-70.
16. Cordle, A., J. Koenigsknecht-Talboo, B. Wilkinson, A. Limpert, and G. Landreth. 2005. Mechanisms of statin-mediated inhibition of small G-protein function. J. Biol. Chem. 280:34202-34209.
17. Crawford, M. A., C. V. Aylott, R. W. Bourdeau, and G. M. Bokoch. 2006. Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity. J. Immunol. 176:7557-7565.
18. Delbosc, S., M. Morena, F. Djouad, C. Ledoucen, B. Descomps, and J. P. Cristol. 2002. Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes. J. Cardiovasc. Pharmacol. 40:611-617.
19. DerMardirossian, C., and G. M. Bokoch. 2005. GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol. 15:356-363.
20. Dixon, T. C., M. Meselson, J. Guillemin, and P. C. Hanna. 1999. Anthrax. N. Engl. J. Med. 341:815-826.
21. Duesbery, N. S., C. P. Webb, S. H. Leppla, V. M. Gordon, K. R. Klimpel, T. D. Copeland, N. G. Ahn, M. K. Oskarsson, K. Fukasawa, K. D. Paull, and G. F. Vande Woude. 1998. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280:734-737.
22. During, R. L., W. Li, B. Hao, J. M. Koenig, D. S. Stephens, C. P. Quinn, and F. S. Southwick. 2005. Anthrax lethal toxin paralyzes neutrophil actin-based motility. J. Infect. Dis. 192:837-845.
23. Eblen, S. T., J. K. Slack, M. J. Weber, and A. D. Catling. 2002. Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes. Mol. Cell. Biol. 22:6023-6033.
24. Ellis, S., and H. Mellor. 2000. Regulation of endocytic traffic by rho family GTPases. Trends Cell Biol. 10:85-88.
25. Fang, H., L. Xu, T. Y. Chen, J. M. Cyr, and D. M. Frucht. 2006. Anthrax lethal toxin has direct and potent inhibitory effects on B-cell proliferation and immunoglobulin production. J. Immunol. 176:6155-6161.
26. Fernandez-Borja, M., L. Janssen, D. Verwoerd, P. Hordijk, and J. Neefjes. 2005. RhoB regulates endosome transport by promoting actin assembly on endosomal membranes through Dia1. J. Cell Sci. 118:2661-2670.
27. Friedlander, A. M. 1986. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J. Biol. Chem. 261:7123-7126.
28. Fukao, T. 2004. Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity. Lancet Infect. Dis. 4:166-170.
29. Garrington, T. P., and G. L. Johnson. 1999. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11:211-218.
30. Genth, H., J. Huelsenbeck, B. Hartmann, F. Hofmann, I. Just, and R. Gerhard. 2006. Cellular stability of Rho-GTPases glucosylated by Clostridium difficile toxin B. FEBS Lett. 580:3565-3569.
31. Gerwins, P., J. L. Blank, and G. L. Johnson. 1997. Cloning of a novel mitogen-activated protein kinase kinase kinase, MEKK4, that selectively regulates the c-Jun amino terminal kinase pathway. J. Biol. Chem. 272:8288-8295.
32. Goldstein, J. L., and M. S. Brown. 1990. Regulation of the mevalonate pathway. Nature 343:425-430.
33. Grip, O., S. Janciauskiene, and S. Lindgren. 2002. Atorvastatin activates PPAR-γ and attenuates the inflammatory response in human monocytes. Inflamm. Res. 51:58-62.
34. Gutting, B. W., K. S. Gaske, A. S. Schilling, A. F. Slaterbeck, L. Sobota, R. S. Mackie, and T. L. Buhr. 2005. Differential susceptibility of macrophage cell lines to Bacillus anthracis-Vollum 1B. Toxicol. In Vitro 19:221-229.
35. Hammond, S. E., and P. C. Hanna. 1998. Lethal factor active-site mutations affect catalytic activity in vitro. Infect. Immun. 66:2374-2378.
36. Jaffe, A. B., and A. Hall. 2005. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21:247-269.
37. Just, I., and R. Gerhard. 2004. Large clostridial cytotoxins. Rev. Physiol. Biochem. Pharmacol. 152:23-47.
38. Just, I., J. Selzer, M. Wilm, C. von Eichel-Streiber, M. Mann, and K. Aktories. 1995. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375:500-503.
39. Kau, J. H., C. G. Lin, H. H. Huang, H. L. Hsu, K. C. Chen, Y. P. Wu, and H. C. Lin. 2002. Calyculin A sensitive protein phosphatase is required for Bacillus anthracis lethal toxin induced cytotoxicity. Curr. Microbiol. 44:106-111.
40. Kirby, J. E. 2004. Anthrax lethal toxin induces human endothelial cell apoptosis. Infect. Immun. 72:430-439.
41. Klimpel, K. R., N. Arora, and S. H. Leppla. 1994. Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol. Microbiol. 13:1093-1100.
42. Klimpel, K. R., S. S. Molloy, G. Thomas, and S. H. Leppla. 1992. Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. Proc. Natl. Acad. Sci. USA 89:10277-10281.
43. Kojro, E., G. Gimpl, S. Lammich, W. Marz, and F. Fahrenholz. 2001. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc. Natl. Acad. Sci. USA 98:5815-5820.
44. Kolch, W. 2000. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 351 Pt. 2:289-305.
45. Kwak, B., F. Mulhaupt, S. Myit, and F. Mach. 2000. Statins as a newly recognized type of immunomodulator. Nat. Med. 6:1399-1402.
46. Lacy, D. B., and R. J. Collier. 2002. Structure and function of anthrax toxin. Curr. Top. Microbiol. Immunol. 271:61-85.
47. Lamaze, C., T. H. Chuang, L. J. Terlecky, G. M. Bokoch, and S. L. Schmid. 1996. Regulation of receptor-mediated endocytosis by Rho and Rac. Nature 382:177-179.
48. Leppla, S. H. 1982. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc. Natl. Acad. Sci. USA 79:3162-3166.
49. Lerner, E. C., Y. Qian, M. A. Blaskovich, R. D. Fossum, A. Vogt, J. Sun, A. D. Cox, C. J. Der, A. D. Hamilton, and S. M. Sebti. 1995. Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes. J. Biol. Chem. 270:26802-26806.
50. Lerner, E. C., Y. Qian, A. D. Hamilton, and S. M. Sebti. 1995. Disruption of oncogenic K-Ras4B processing and signaling by a potent geranylgeranyltransferase I inhibitor. J. Biol. Chem. 270:26770-26773.
51. Liao, J. K. 2002. Isoprenoids as mediators of the biological effects of statins. J. Clin. Investig. 110:285-288.
52. Liao, J. K., and U. Laufs. 2005. Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol. 45:89-118.
53. Lin, C. G., Y. T. Kao, W. T. Liu, H. H. Huang, K. C. Chen, T. M. Wang, and H. C. Lin. 1996. Cytotoxic effects of anthrax lethal toxin on macrophage-like cell line J774A. 1. Curr. Microbiol. 33:224-227.
54. Liu, S., and S. H. Leppla. 2003. Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization. J. Biol. Chem. 278:5227-5234.
55. Lunin, V. V., C. Munger, J. Wagner, Z. Ye, M. Cygler, and M. Sacher. 2004. The structure of the MAPK scaffold, MP1, bound to its partner, p14: a complex with a critical role in endosomal MAP kinase signaling. J. Biol. Chem. 279:23422-23430.
56. Milne, J. C., and R. J. Collier. 1993. pH-dependent permeabilization of the plasma membrane of mammalian cells by anthrax protective antigen. Mol. Microbiol. 10:647-653.
57. Milne, J. C., D. Furlong, P. C. Hanna, J. S. Wall, and R. J. Collier. 1994. Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J. Biol. Chem. 269:20607-20612.
58. Moayeri, M., and S. H. Leppla. 2004. The roles of anthrax toxin in pathogenesis. Curr. Opin. Microbiol. 7:19-24.
59. Mourez, M. 2004. Anthrax toxins. Rev. Physiol. Biochem. Pharmacol. 152:135-164.
60. Na, X., D. Zhao, H. W. Koon, H. Kim, J. Husmark, M. P. Moyer, C. Pothoulakis, and J. T. LaMont. 2005. Clostridium difficile toxin B activates the EGF receptor and the ERK/MAP kinase pathway in human colonocytes. Gastroenterology 128:1002-1011.
61. Ohren, J. F., H. Chen, A. Pavlovsky, C. Whitehead, E. Zhang, P. Kuffa, C. Yan, P. McConnell, C. Spessard, C. Banotai, W. T. Mueller, A. Delaney, C. Omer, J. Sebolt-Leopold, D. T. Dudley, I. K. Leung, C. Flamme, J. Warmus, M. Kaufman, S. Barrett, H. Tecle, and C. A. Hasemann. 2004. Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition. Nat. Struct. Mol. Biol. 11:1192-1197.
62. Ortego, M., C. Bustos, M. A. Hernandez-Presa, J. Tunon, C. Diaz, G. Hernandez, and J. Egido. 1999. Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis 147:253-261.
63. Paccani, S. R., F. Tonello, R. Ghittoni, M. Natale, L. Muraro, M. M. D'Elios, W. J. Tang, C. Montecucco, and C. T. Baldari. 2005. Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. J. Exp. Med. 201:325-331.
64. Paccani, S. R., F. Tonello, L. Patrussi, N. Capitani, M. Simonato, C. Montecucco, and C. T. Baldari. 2007. Anthrax toxins inhibit immune cell chemotaxis by perturbing chemokine receptor signalling. Cell Microbiol. 9:924-929.
65. Pahan, K., F. G. Sheikh, A. M. Namboodiri, and I. Singh. 1997. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J. Clin. Investig. 100:2671-2679.
66. Pannifer, A. D., T. Y. Wong, R. Schwarzenbacher, M. Renatus, C. Petosa, J. Bienkowska, D. B. Lacy, R. J. Collier, S. Park, S. H. Leppla, P. Hanna, and R. C. Liddington. 2001. Crystal structure of the anthrax lethal factor. Nature 414:229-233.
67. Park, J. M., F. R. Greten, Z. W. Li, and M. Karin. 2002. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297:2048-2051.
68. Pellizzari, R., C. Guidi-Rontani, G. Vitale, M. Mock, and C. Montecucco. 1999. Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNγ-induced release of NO and TNF. FEBS Lett. 462:199-204.
69. Petosa, C., R. J. Collier, K. R. Klimpel, S. H. Leppla, and R. C. Liddington. 1997. Crystal structure of the anthrax toxin protective antigen. Nature 385:833-838.
70. Pezard, C., P. Berche, and M. Mock. 1991. Contribution of individual toxin components to virulence of Bacillus anthracis. Infect. Immun. 59:3472-3477.
71. Popov, S. G., R. Villasmil, J. Bernardi, E. Grene, J. Cardwell, T. Popova, A. Wu, D. Alibek, C. Bailey, and K. Alibek. 2002. Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells. FEBS Lett. 527:211-215.
72. Popov, S. G., R. Villasmil, J. Bernardi, E. Grene, J. Cardwell, A. Wu, D. Alibek, C. Bailey, and K. Alibek. 2002. Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochem. Biophys. Res. Commun. 293:349-355.
73. Rainey, G. J., and J. A. Young. 2004. Antitoxins: novel strategies to target agents of bioterrorism. Nat. Rev. Microbiol. 2:721-726.
74. Ribot, W. J., R. G. Panchal, K. C. Brittingham, G. Ruthel, T. A. Kenny, D. Lane, B. Curry, T. A. Hoover, A. M. Friedlander, and S. Bavari. 2006. Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survival. Infect. Immun. 74:5029-5034.
75. Ridley, A. J. 2001. Rho family proteins: coordinating cell responses. Trends Cell Biol. 11:471-477.
76. Scobie, H. M., G. J. Rainey, K. A. Bradley, and J. A. Young. 2003. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc. Natl. Acad. Sci. USA 100:5170-5174.
77. Scobie, H. M., and J. A. T. Young. 2005. Interactions between anthrax toxin receptors and protective antigen. Curr. Opin. Microbiol. 8:106-112.
78. Slack-Davis, J. K., S. T. Eblen, M. Zecevic, S. A. Boerner, A. Tarcsafalvi, H. B. Diaz, M. S. Marshall, M. J. Weber, J. T. Parsons, and A. D. Catling. 2003. PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation. J. Cell Biol. 162:281-291.
79. Stofega, M., C. DerMardirossian, and G. M. Bokoch. 2006. Affinity-based assay of Rho guanosine triphosphatase activation. Methods Mol. Biol. 332:269-279.
80. Sun, J., Y. Qian, A. D. Hamilton, and S. M. Sebti. 1995. Ras CAAX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-Ras mutation and p53 deletion. Cancer Res. 55:4243-4247.
81. Takai, Y., T. Sasaki, and T. Matozaki. 2001. Small GTP-binding proteins. Physiol. Rev. 81:153-208.
82. Tanoue, T., M. Adachi, T. Moriguchi, and E. Nishida. 2000. A conserved docking motif in MAP kinases common to substrates, activators, and regulators. Nat. Cell Biol. 2:110-116.
83. Turk, B. E. 2007. Manipulation of host signalling pathways by anthrax toxins. Biochem. J. 402:405-417.
84. Vitale, G., L. Bernardi, G. Napolitani, M. Mock, and C. Montecucco. 2000. Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem. J. 352(Pt. 3):739-745.
85. Vitale, G., R. Pellizzari, C. Recchi, G. Napolitani, M. Mock, and C. Montecucco. 1998. Anthrax lethal factor cleaves the N terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. 248:706-711.
86. Xia, Y., Z. Wu, B. Su, B. Murray, and M. Karin. 1998. JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension. Genes Dev. 12:3369-3381.
87. Zhang, F. L., and P. J. Casey. 1996. Protein prenylation: molecular mechanisms and functional consequences. Annu. Rev. Biochem. 65:241-269.